GINECOLOGIA (215)

Prévia do material em texto

194 Ginecología general
SECCIÓ
N
 1
Creinin MD, Schreiber CA, Bednarek P, et al: Mifepristone and misoprostol 
administered simultaneously versus 24 hours apart for abortion: a random-
ized controlled trial. Obstet Gynecol 109(4):885, 2007
Cremer M, Bullard KA, Mosley RM: Immediate vs. delayed post-abortal copper 
T 380A IUD insertion in cases over 12 weeks of gestation. Contraception 
83(6):522, 2011
Cunningham FG, Leveno KL, Bloom SL, et al. (eds): Abortion. In Williams 
Obstetrics, 23rd ed. New York, McGraw-Hill, 2010a, p 215
Cunningham FG, Leveno KL, Bloom SL, et al. (eds): Connective-tissue disor-
ders. In Williams Obstetrics, 23rd ed. New York, McGraw-Hill, 2010b, p 
1145
Cunningham FG, Leveno KL, Bloom SL, et al. (eds): Genetics. In Williams 
Obstetrics, 23rd ed. New York, McGraw-Hill, 2010c, p 273
Cunningham FG, Leveno KL, Bloom SL, et al. (eds): Prenatal care. In Williams 
Obstetrics, 23rd ed. New York, McGraw-Hill, 2010d, p 207
Daif JL, Levie M, Chudnoff S, et al: Group a Streptococcus causing necrotizing 
fasciitis and toxic shock syndrome after medical termination of pregnancy. 
Obstet Gynecol 113(2 Pt 2):504, 2009
Dalenda C, Ines N, Fathia B, et al: Two medical abortion regimens for late 
fi rst-trimester termination of pregnancy: a prospective randomized trial. 
Contraception 81(4):323, 2010
Dalton VK, Harris LH, Gold KJ, et al: Provider knowledge, attitudes, and treatment 
preferences for early pregnancy failure. Am J Obstet Gynecol 202:531.e1, 2010
Dao B, Blum J, Th ieba B, et al: Is misoprostol a safe, eff ective and acceptable 
alternative to manual vacuum aspiration for postabortion care? Results from 
a randomized trial in Burkina Faso, West Africa. BJOG 114(11):1368, 2007
Daya S: Accuracy of gestational age estimation by means of fetal crown-rump 
length measurement. Am Journal Obstet Gynecol 168(3 Pt 1):903, 1993
De Vivo A, Mancuso A, Giacobbe A, et al: Th yroid function in women found 
to have early pregnancy loss. Th yroid 20(6):633, 2010
Devaseelan P, Fogarty PP, Regan L: Human chorionic gonadotropin for 
threatened abortion. Cochrane Database Syst Rev 5:DC007422, 2010
Devi Wold AS, Pham N, Arici A: Anatomic factors in recurrent pregnancy loss. 
Semin Reprod Med 1:25, 2006
Di Simone N, Meroni PL, D’Asta M, et al: Pathogenic role of anti-beta2-
glycoprotein I antibodies on human placenta: functional eff ects related to 
implantation and roles of heparin. Hum Reprod Update 13(2):189, 2007
Dizon-Townsend D, Miller C, Sibai B, et al: Th e relationship of the factor 
V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet 
Gynecol 106:517, 2005
Dolitzky M, Inbal A, Segal Y, et al: A randomized study of thromboprophylaxis 
in women with unexplained consecutive recurrent miscarriages. Fertil Steril 
86:362, 2006
Dranitsaris G, Johnston M, Poirier S, et al: Are health care providers who work 
with cancer drugs at an increased risk for toxic events? A systematic review 
and meta-analysis of the literature. J Oncol Pharm Pract 2:69, 2005
Dukhovny S, Zutshi P, Abbott JF: Recurrent second trimester pregnancy loss: 
evaluation and management. Curr Opin Endocrinol Diabetes Obes 16:451, 
2009
Eddleman K, Sullivan L, Stone J, et al: An individualized risk for spontaneous 
pregnancy loss: a risk function model. J Soc Gynecol Investig 13:197A, 2006
Eiben B, Bartels I, Bahr-Prosch S, et al: Cytogenetic analysis of 750 spontane-
ous abortions with the direct-preparation method of chorionic villi and its 
implications for studying genetic causes of pregnancy wastage. Am J Hum 
Genet 47:656, 1990
Eller AG, Branch DW, Nelson L, et al: Vascular endothelial growth factor-A 
gene polymorphisms in women with recurrent pregnancy loss. J Reprod 
Immunol 88(1):48, 2011
Empson M, Lassere M, Craig J, et al: Prevention of recurrent miscarriage for 
women with antiphospholipid antibody or lupus anticoagulant. Cochrane 
Database Syst Rev (2):CD002859, 2005. Edited with no change in conclu-
sions, Issue 1, 2010
Erkan D, Kozora E, Lockshin MD: Cognitive dysfunction and white matter 
abnormalities in antiphospholipid syndrome. Pathophysiology 18(1):93, 
2011
Eskenazi B, Chevrier J, Rosas LG, et al: Th e Pine River statement: human health 
consequences of DDT use. Environ Health Perspect 117(9):1359, 2009
Fantel AG, Shepard TH, Vadheim-Roth C, et al: Embryonic and fetal pheno-
types: Prevalence and other associated factors in a large study of spontane-
ous abortion. In Porter IH, Hook EM (eds): Human Embryonic and Fetal 
Death. New York, Academic Press, 1980, p 71
Farquharson RG, Quenby S, Greaves M: Antiphospholipid syndrome in 
pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 
100:408, 2002
Feist A, Sydler T, Gebbers JJ, et al: No association of Chlamydia with abortion. 
J R Soc Med 92:237, 1999
Fekih M, Fathallah K, Ben Regaya L, et al: Sublingual misoprostol for fi rst 
trimester termination of pregnancy. Int J Gynaecol Obstet 109(1):67, 2010
Feldman DM, Timms D, Borgida AF: Toxoplasmosis, parvovirus, and cyto-
megalovirus in pregnancy. Clin Lab Med 30(3):709, 2010
Fischer J, Colls P, Esudero T, et al: Preimplantation genetic diagnosis (PGD) 
improves pregnancy outcome for translocation carriers with a history of 
recurrent losses. Fertil Steril 94(1):283, 2010
Fischer M, Bhatnagar J, Guarner J, et al: Fatal toxic shock syndrome associated 
with Clostridium sordellii after medical abortion. N Engl J Med 353:2352, 
2005
Fjerstad M, Sivin I, Lichtenberg ES, et al: Eff ectiveness of medical abortion 
with mifepristone and buccal misoprostol through 59 gestational days. 
Contraception 80(3):282, 2009a
Fjerstad M, Trussell, J, Sivin I: Rates of serious infection after changes in 
regimens for medical abortion. N Engl J Med 361:145, 2009b
Flood K, Peace A, Kent E, et al: Platelet reactivity and pregnancy loss. Am 
J Obstet Gynecol 203:281.e1, 2010
Floyd RL, Decoufl e P, Hungerford DW: Alcohol use prior to pregnancy 
recognition. Am J Prev Med 17:101, 1999
Fox MC, Oat-Judge J, Severson K: Immediate placement of intrauterine devices 
after fi rst and second trimester pregnancy termination. Contraception 
83(1):34, 2011 
Franklin RD, Kutteh WH: Eff ects of unfractionated and low molecular weight 
heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 
101:455, 2003
Franssen MTM, Korevaar JC, van der Veen F, et al: Reproductive outcome 
after chromosome analysis in couples with two or more miscarriages: case-
control study. BMJ 332:750, 2006
Franz MB, Husslein PW: Obstetrical management of the older gravida. 
Womens Health 6(3):463, 2010
Freedman L, Landy U, Steinauer J: Obstetrician-gynecologist experiences with 
abortion training: physician insights from a qualitative study. Contraception 
81(6):525, 2010
Gallicchio L, Miller S, Greene T, et al: Cosmetologists and reproductive out-
comes. Obstet Gynecol 113(5):1018, 2009
Ganer H, Levy A, Ohel I, et al: Pregnancy outcome in women with an intra-
uterine contraceptive device. Am J Obstet Gynecol 201:381.e1, 2009
Glueck CJ, Wang P, Goldenberg N, et al: Pregnancy outcomes among women 
with polycystic ovary syndrome treated with metformin. Hum Reprod 
17:2858, 2002
Goel N, Tuli A, Choudhry R: Th e role of aspirin versus aspirin and heparin in 
cases of recurrent abortions with raised anticardiolipin antibodies. Med Sci 
Monit 12:CR132, 2006
Goldberg AB, Dean G, Kang MS, et al: Manual versus electric vacuum aspira-
tion for early fi rst-trimester abortion: a controlled study of complication 
rates. Obstet Gynecol 103:101, 2004
Goldenberg M, Sivan E, Sharabi Z, et al: Reproductive outcome following hys-
teroscopic management of intrauterine septum and adhesions. Hum Reprod 
10:2663, 1995
Goldstein SR: Signifi cance of cardiac activity on endovaginal ultrasound in 
very early embryos. Obstet Gynecol 80(4):670, 1992
Goodman C, Hur J, Goodman CS, et al: Are polymorphisms in the ACE 
and PAI-1 genes associated with recurrent spontaneous miscarriages? Am 
J Reprod Immunol 62(6):365,2009
Gracia CR, Sammel MD, Chittams J, et al: Risk factors for spontaneous 
abortion in early symptomatic fi rst-trimester pregnancies. Obstet Gynecol 
106:993, 2005
Greene MF: Spontaneous abortions and major malformations in women with 
diabetes mellitus. Semin Reprod Endocrinol 17:127, 1999
Grimes DA: Estimation of pregnancy-related mortality risk by pregnancy out-
come, United States, 1991 to 1999. Am J Obstet Gynecol 194:92, 2006
Grimes DA, Lopez LM, Schulz KF, et al: Immediate postabortal insertion of 
intrauterine devices. Cochrane Database Syst Rev 6:CD001777, 2010
Guelinckx I, Devlieger R, Vansant G: Reproductive outcome after bariatric 
surgery: a critical review. Hum Reprod Update 15(2):189, 2009
Guest J, Chien PF, Th omson MA, et al: Randomised controlled trial compar-
ing the effi cacy of same-day administration of mifepristone and misoprostol 
for termination of pregnancy with the standard 36 to 48 hour protocol. 
BJOG 114(2):207, 2007
Guttmacher Institute: State facts about abortion: Texas. September, 2008. 
Available at: http://www.guttmacher.org/pubs/sfaa/texas.html. Accessed 
March 23, 2011
Guttmacher Institute: US abortion rate levels off after 30-year decline. Reuters 
Health Information, January 12, 2011
Haas DM, Ramsey PS: Progesterone for preventing miscarriage. Cochrane 
Database Syst Rev 2:CD003511, 2008
Haddow JE, McClain MR, Palomaki GE, et al: Th yroperoxidase and 
thyroglobulin antibodies in early pregnancy and placental abruption. Obstet 
Gynecol 117:287, 2011
Hamoda H, Ashok PW, Flett GMM, Templeton A: A randomised controlled 
trial of mifepristone in combination with misoprostol administered sublin-
06_Chapter_06_Hoffman_4R.indd 19406_Chapter_06_Hoffman_4R.indd 194 06/09/13 20:5506/09/13 20:55